- ICH GCP
- US Clinical Trials Registry
- Researchers
- Canada
- Hypersensitivity
Medical specialists from Canada tagged as investigators in clinical trials studying Hypersensitivity
Total 49 results
-
Alannah Smrke, MDSeen in:
- British Columbia, Vancouver, BC Cancer - Vancouver
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Alexandra Langlois, MDSeen in:
- Quebec, Sherbrooke, CIUSSS de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CHUS)
Trials:- NCT04045301 (Principal Investigator)
-
Amit OzaSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, Princess Margaret Cancer Centre - University Health Network
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network - Princess Margaret Hospital
- Ontario, Toronto, University Health Network, Princess Margaret Hospital
- Ontario, Toronto, University health Network (UHN)-University of Toronto
- Toronto, Princess Margaret Cancer Center
- Toronto, Princess Margaret Cancer Centre
Trials:- NCT05483933 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT04625270 (Principal Investigator)
- NCT05229900 (Principal Investigator)
- NCT04159155 (Principal Investigator)
- NCT02334761 (Principal Investigator)
- NCT05870748 (Principal Investigator)
- NCT06003231 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Peritoneal Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Low Grade Ovarian Serous Adenocarcinoma;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Testicular Neoplasms;
- Carcinoma, Non-Small-Cell Lung;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Gastroesophageal Junction Carcinoma;
- Endometrial Carcinoma;
- P53 Mutation;
- Serous Carcinoma;
- Pathology;
- Primary Peritoneal Cancer;
- Carcinoma, Squamous Cell of Head and Neck
-
Andrew Dixon, MDSeen in:
- Alberta, Edmonton, Stollery Children's Hospital
Trials:- NCT03851835 (Principal Investigator)
- NCT03567473 (Principal Investigator)
- NCT05135377 (Principal Investigator)
Conditions: -
Andrew Robinson, MDSeen in:
- Ontario, Kingston, Kinston Health Sciences Center - KGH Site
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Anna Taddio, PhDSeen in:
- Ontario, Toronto, The Hospital for Sick Children
Trials:- NCT01503060 (Principal Investigator)
- NCT00298584 (Principal Investigator)
Conditions: -
Anna TinkerSeen in:
- British Columbia, Vancouver, BC Cancer Vancouver
Trials:- NCT05456685 (Principal Investigator)
-
April RoseSeen in:
- Quebec, Montreal, Jewish General Hospital
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Daniel J KhalafSeen in:
- British Columbia, Vancouver, BC Cancer Vancouver
Trials:- NCT05288166 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6
-
Diane ProvencherSeen in:
- Montréal, Centre de recherche di Centre Hospitalier de i'Universite de Montreal
- Quebec, Montreal, CHUM
- Quebec, Montreal, Centre Hospitalier de L'Universite de Montreal - Centre de Recherche
- Quebec, Montréal, CHUM - Centre Hospitalier de l'Universite de Montreal
- Quebec, Montréal, CHUM - University of Montreal Hospital Centre
- Quebec, Montréal, Centre Hospitalier de l'Universite de Montreal (CHUM)
- Quebec, Montréal, Centre Hospitalier de l'Université de Montréal
Trials:- NCT05456685 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05329545 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT05358639 (Principal Investigator)
- NCT04625270 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT04706962 (Principal Investigator)
- NCT05243524 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- High Grade Serous Ovarian Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- High Grade Serous Carcinoma;
- Low Grade Ovarian Serous Adenocarcinoma;
- Peritoneal Cancer;
- Solid Tumor;
- Prostate Cancer;
- Epithelial Ovarian Cancer;
- Small-cell Lung Cancer;
- Thyroid Cancer;
- Cutaneous Melanoma;
- TNBC - Triple-Negative Breast Cancer;
- Hormone Receptor-positive Breast Cancer;
- SORT1+ Cancers;
- Platinum-resistant Epithelial Ovarian Cancer
-
Douglas Mack, MDSeen in:
- Ontario, Burlington, Halton Pediatric Allergy
Trials:- NCT04492683 (Principal Investigator)
Conditions: -
Douglas P Mack, MDSeen in:
- Ontario, Burlington, Halton Pediatric Allergy
Trials:- NCT05440643 (Principal Investigator)
Conditions: -
Dr. Alannah SmrkeSeen in:
- British Columbia, Vancouver, BC Cancer - Vancouver
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Grace Bravo, MDSeen in:
- Ontario, London, Children's Hospital of Western Ontario
Trials:- NCT05135377 (Principal Investigator)
Conditions: -
Jason Ohayon, MDSeen in:
- Ontario, Hamilton, Hamilton Allergy
Trials:- NCT04492683 (Principal Investigator)
Conditions: -
Jennifer Rauw, MDSeen in:
- Alberta, Edmonton, University of Alberta - Cross Cancer Institute (CCI)
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Jocelyn Gravel, MDSeen in:
- Quebec, Montreal, Centre Hospitalier Universitaire Sainte-Justine
Trials:- NCT05135377 (Principal Investigator)
Conditions: -
Johanne Weberpals, MDSeen in:
- Ontario, Ottawa, The Ottawa Hospital Cancer Centre
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Julia Upton, MDSeen in:
- Ontario, Toronto, The Hospital for Sick Children
Trials:- NCT04045301 (Principal Investigator)
-
Lara DE GUERKESeen in:
- Montréal, CIUSSS de l'Est-de-I'lle-de-Montreal Hopital Maisonneuve-Rosemont (CAHA)
- Quebec, Montreal, Universite de Montreal - Hopital Maisonneuve-Rosemont (HMR)
Trials:- NCT03386734 (Principal Investigator)
- NCT05445778 (Principal Investigator)
Conditions: -
Lara deGuerke, MDSeen in:
- Quebec, Montreal, Universite de Montreal - Hopital Maisonneuve-Rosemont (HMR)
Trials:- NCT05445778 (Principal Investigator)
Conditions: -
Lucy GilbertSeen in:
- Quebec, Montreal, McGill University Department of Oncology / McGill University Health Centre
- Quebec, Montreal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Care
- Quebec, Montréal, McGill University Health Centere (MUHC)-Glen Site
- Quebec, Montréal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Centre (MUHC)
Trials:- NCT05456685 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT06003231 (Principal Investigator)
- NCT05483933 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT05870748 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Endometrial Cancer;
- Neoplasms;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Ovarian Cancer;
- Rectal Cancer;
- Triple Negative Breast Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Carcinoma, Non-Small-Cell Lung;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Carcinoma, Squamous Cell of Head and Neck;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Peritoneal Cancer
-
María Inés Pinto-Sánchez, MDSeen in:
- Ontario, Hamilton, McMaster Health Sciences Centre
Trials:- NCT03059862 (Sub-Investigator)
- NCT03089632 (Sub-Investigator)
-
Martin SmoragiewiczSeen in:
- Ontario, Toronto, GSK Investigational Site
- Ontario, Toronto, Sunnybrook Health Sciences Centre
- Ontario, Toronto, Sunnybrook Research Institute
Trials:- NCT05288166 (Principal Investigator)
- NCT06062420 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Neoplasms, Head and Neck
-
Mohamed Eltorki, MDSeen in:
- Ontario, Hamilton, McMaster Children's Hospital
- Ontario, Hamilton, McMaster University
Trials:- NCT03361371 (Principal Investigator)
- NCT05135377 (Principal Investigator)
Conditions: -
Moshe Ben-Shoshan, MDSeen in:
- Quebec, Montreal, Research Institute of the McGill University Health Centre
Trials:- NCT06256146 (Principal Investigator)
Conditions:
Clinical Trials on Hypersensitivity
-
National Institute of Allergy and Infectious Diseases...Consortium of Food Allergy ResearchCompletedMilk Hypersensitivity | Egg Hypersensitivity | Food Hypersensitivity | Peanut HypersensitivityUnited States
-
Ospedale Buon Consiglio FatebenefratelliCompleted- Egg HypersensitivityItaly
-
IRCCS Burlo GarofoloCompleted
-
National Institute of Allergy and Infectious Diseases...Consortium of Food Allergy ResearchCompletedHypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity | Immediate HypersensitivityUnited States
-
Johns Hopkins UniversityCompletedFood Hypersensitivity | Peanut Hypersensitivity | Immediate HypersensitivityUnited States
-
Allertein Therapeutics, LLCConsortium of Food Allergy ResearchCompletedHypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity | Immediate HypersensitivityUnited States
-
Alton MeltonThe Cleveland ClinicActive, not recruiting
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)Completed
-
National Institute of Allergy and Infectious Diseases...Consortium of Food Allergy ResearchCompletedHypersensitivity | Food Hypersensitivity | Hypersensitivity, Immediate | Peanut HypersensitivityUnited States
-
University of North Carolina, Chapel HillGenentech, Inc.CompletedPeanut HypersensitivityUnited States